Background: Detection of malignant liver mass is very important for the treatment modalities. Objective: The purpose of the present study was to establish the usefulness of CT scan in the diagnosis of malignant hepatic mass. Methodology: This cross sectional study was carried out in the Department of Radiology and Imaging at Mymensingh Medical College Hospital (MMCH), Mymensingh, Banghabandhu Sheikh Mujib Medical University (BSMMU), Dhaka and Dhaka Medical College Hospital (DMCH), Dhaka during the period of 1st January 2006 to 31st December 2007. Patients admitted in the Department of Medicine and Department of Hepatobiliary of MMCH, BSMMU, and DMCH with the clinical diagnosis of fever, abdominal pain, anorexia, nausea/vomiting, loss of appetite, jaundice, weight loss and ascites were selected as study population. CT scan and histopathology were performed to all the patients. Result: A total number of 50 patients were recruited for this study. Mean age of all patients was 51.28 ± 14 years with a range of 17 year to 78 years. Among all patients 28 had multiple lesion, of them 71.4% was malignant and 28.6% was benign. On the other side 22 patients had solitary lesion, of them 36.4% was malignant and 63.6% was benign (p < 0.05). Sensitivity of CT to diagnose malignant lesion was 96.4%, specificity 86.4%, accuracy 92%, positive predictive value 90% and negative predictive value 95%. Conclusion: CT is a useful diagnostic tool for the detection of malignant hepatic masses.
Malignant liver mass, especially hepatocellular carcinoma (HCC), is the most common primary malignant tumour of the liver representing more than 80% of all primary hepatic malignancies [
This cross sectional study was carried out in the Department of Radiology and Imaging of three tertiary care hospitals in Bangladesh named as Mymensingh Medical College Hospital, Mymensingh; Dhaka Medical College Hospital, Dhaka and Banghabandhu Sfheikh Mujib Medical University (BSMMU), Dhaka in collaboration with the Department of Pathology of the same institute for histopathological diagnosis from 1st January 2006 to 31st December 2007 for a period of 2 years. All the clinically suspected patients having hepatic mass at any age with both sexes who were attended in three hospitals were taken as study population as per inclusion and exclusion criteria. Patients having hepatomegaly due to extra hepatic causes, patients who refused to undergo CT-scan, patients who refuse to do biopsy or whose biopsy result was not available and patients having known hypersensitivity reaction to contrast agent were excluded from this study. Purposive sampling technique was used to collect the patients. Prior to the commencement of this study, the research protocol was approved by the ethics review committee of the respective hospital. Each patient was undergone CT examination of hepatobiliary system (HBS) at the Department of Radiology and Imaging. All CT-scan were performed with a third generation CT- scan (Siemans). Somatom (2 - 5) mm thick contiguous slice were taken. These scan were obtained using 120 kv, 75 mm and 0.8 see scanning time for 2 slice. Both pre and post contrast were performed. Oral contrast medium was routinely administrated before the examination. Immediately after completion of bolus injection 8mm contiguous slice were obtained through the upper abdomen by CT-scan. All collected biopsy tissues were sent for histopathological examination in the histopathology department of respective hospital and collected reports were compared with CT-scan diagnosis.
Percentages were calculated to find out the proportion of the findings. Further statistical analysis of the results was done by computer software devised as the statistical package for the social sciences (SPSS, windows version 16.0). For the validity of the study outcome sensitivity, specificity, accuracy, positive and negative predictive values were calculated after confirmation of the diagnosis histopathologically. For significance of differences was done using Student’s t test and Chi-square test where applicable. Statistical significance was set at p value less than 0.05 and confidence interval was set at 95% level. All probability values quoted were 2-tailed. The sampling technique was by purposive sampling technique. The 80% statistical power was taken with a 5% statistical error. The ultimate sample size was calculated by single group of study population.
A total number of 50 clinically diagnosed hepatomegaly patients were recruited in the study. The mean (±SD) age of the respondents was 51.28 (±14.06) years. Males (80.0%) were more predominant than females (20.0%). The male and female ratio was found 4:1. Statistical analysis of patients of both sex has revealed that they were within similar age distribution (p = 0.617). Mean age of male was 50.78 (±13.68) years whereas female was 53.3 (±16.11) years. Age range of the total patients was 17 year to 78 years. Maximum patients were within 470 to 60 years which was 29 (58.0%) cases (
Hepatic masses come to clinical attention when these are felt by the patient as well as discovered on physical examination by the physician or most commonly detected on diagnostic radiological studies [
Age group | Sex | Total | |
---|---|---|---|
Male | Female | ||
Less than 20 years | 0 (0.0%) | 1 (10.0%) | 1 (2.0%) |
20 to 40 years | 9 (22.5%) | 0 (0.0%) | 9 (18.0%) |
40 to 60 years | 23 (57.5%) | 6 (60.0%) | 29 (58.0%) |
More than 60 years | 8 (20.0%) | 3 (30.0%) | 11 (22.0%) |
Total | 40 (100.0%) | 10 (100.0%) | 50 (100.0%) |
Mean ± SD | 50.78 ± 13.68 | 53.30 ± 16.11 |
*Student t test was performed to see the level of significance; p value 0.617.
CT-scan diagnosis | Histopathological diagnosis | Total | |
---|---|---|---|
Malignant | Not malignant | ||
Malignant | 27 (96.4%) | 3 (13.6%) | 30 (60.0%) |
Not malignant | 1 (3.6%) | 19 (86.4%) | 20 (40.0%) |
Total | 28 (100.0%) | 22 (100.0%) | 50 (100.0%) |
*Chi square value = 35.187, df = 1, p value = 0.001.
Parameters | Value | 95% CI |
---|---|---|
Sensitivity | 96.4% | 91.24% to 101.56% |
Specificity | 86.4% | 76.9% to 95.9% |
PPV | 90.0% | 81.68% to 98.32% |
NPV | 95.0% | 88.96% to 101.04% |
Accuracy | 92.0% | 84.48% to 99.52% |
*95% CI = 95% confidence interval.
advances and the expanded use of imaging modalities have led to the increased documentation of hepatic masses. This study was carried out to determine the accuracy of CT scan examination for the evaluation of hepatic masses and it’s correlation with histopathological examinations.
During the study period from 1st January 2006 to 31st December 2007, total 50 cases were studied who had undergone CT examinations of hepatobiliary system. The final diagnosis of hepatic masses was made by histopathological examinations. Mean age of male of present study was 50.78 years with a std. deviation of ±13.68 whereas female was 53.3 years with std. deviation of ±16.11 years. Age range of the total patients was 17 year to 78 years. Maximum patients were within 40 to 60 years of age group. Statistical analysis of patients of both sex has revealed that they were within similar age distribution (p value = 0.617). Liver mass can occur in a person of any age; however, the incidence is more common in middle aged and elderly persons [
In case of malignant diseases, twenty seven patients were diagnosed as malignant by CT and confirmed by histopathological evaluation. They were true positive. Three patients were diagnosed as malignant by CT but not confirmed by histopathology. They were false positive. Of 20 patients of benign lesions, which were confirmed by CT, 1 was confirmed as malignant and 19 were benign by histopathology. They were false negative and true negative respectively.
Sensitivity of CT to diagnose malignant lesion was 96.4%, specificity 86.4%, accuracy 92%, positive predictive value 90% and negative predictive value 95%. Kang et al. [
The results of the present study therefore conclude that CT is a useful modality for the diagnosis of malignant liver masses. Since the CT diagnosis correlates with histopathological connection, it is a sensitive modality on the basis of the above findings.